-transparent.png){kind=logo}
1 The pharmacokinetics of atenolol, after 200 mg orally, were studied in 18 patients with terminal renal insufficiency (creatinine clearance less than 5 ml/min), of whom twelve were being treated by chronic dialysis. 2 The peak plasma level, 1.59 +/- 0.43 mg/l, was reached in 4.7 +/- 2.1 h. 3 Without dialysis treatment, the apparent plasma half-life of atenolol was greatly increased (73.4 +/- 28.8 /). During dialysis, it dropped to 7.5 +/- 3.7 h but returned to 51.2 +/- 17.3 h after dialysis. The plasma atenolol plot was a rising slope for a few hours after the end of dialysis. 4 Renal clearance of atenolol was very low (4.6 +/- 1.5 ml/min). 5 Plasma clearance during dialysis was 42.6 +/- 21.3 ml/min for a mean blood flow-rate of 236 +/- 25 ml/min through a cuprophane membrane dialyser. 6 These results suggest that dosage should be modified for these patients.
B Flouvat, and
S Decourt, and
P Aubert, and
L Potaux, and
M Domart, and
A Goupil, and
A Baglin
January 1973,
Chemotherapy,
B Flouvat, and
S Decourt, and
P Aubert, and
L Potaux, and
M Domart, and
A Goupil, and
A Baglin
January 1987,
European journal of clinical pharmacology,
B Flouvat, and
S Decourt, and
P Aubert, and
L Potaux, and
M Domart, and
A Goupil, and
A Baglin
November 1977,
Deutsche medizinische Wochenschrift (1946),
B Flouvat, and
S Decourt, and
P Aubert, and
L Potaux, and
M Domart, and
A Goupil, and
A Baglin
July 1976,
Deutsche medizinische Wochenschrift (1946),
B Flouvat, and
S Decourt, and
P Aubert, and
L Potaux, and
M Domart, and
A Goupil, and
A Baglin
January 1973,
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association,
B Flouvat, and
S Decourt, and
P Aubert, and
L Potaux, and
M Domart, and
A Goupil, and
A Baglin
January 1993,
Drugs under experimental and clinical research,
B Flouvat, and
S Decourt, and
P Aubert, and
L Potaux, and
M Domart, and
A Goupil, and
A Baglin
February 1993,
Mechanisms of ageing and development,
B Flouvat, and
S Decourt, and
P Aubert, and
L Potaux, and
M Domart, and
A Goupil, and
A Baglin
November 1977,
European journal of clinical pharmacology,
B Flouvat, and
S Decourt, and
P Aubert, and
L Potaux, and
M Domart, and
A Goupil, and
A Baglin
January 1990,
International journal of clinical pharmacology research,
B Flouvat, and
S Decourt, and
P Aubert, and
L Potaux, and
M Domart, and
A Goupil, and
A Baglin
December 2000,
European journal of clinical pharmacology,
